SLC5A2 and diabetic kidney disease: Increased mTORC1 activity in the proximal tubule in diabetes induces renal fibrosis and renal function decline (24), and targeted mTORC1 inhibition by rapamycin and sodium-glucose cotransporter 2 inhibitors (SGLT2i) is renoprotective in DKD (24–26).